The company is not selling any securities under this prospectus and will not receive any of the proceeds from the sale of shares by the selling stockholder.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ACXP:
- Acurx Pharmaceuticals’ Earnings Call: Progress Amidst Funding Challenges
- Acurx assumed with a Buy at H.C. Wainwright
- Acurx Pharmaceuticals: Promising Antibiotic Developments and Strong Financial Position Justify Buy Rating
- Acurx Pharmaceuticals Reports Improved Q1 2025 Results
- Acurx Pharmaceuticals Enters $12M Stock Purchase Agreement